Series date: 
01/13/2026 - 6:30am CST to 12/31/2026 - 11:59pm CST

OBJECTIVES: Upon completion of this activity, the participant should be able to – (1) Integrate current evidence-based research into routine liver cancer care. (2) Review of the latest NCCN Guidelines. (3) Apply patient-centered approaches to improve outcomes in liver cancer management.

PLANNER/MODERATOR DISCLOSURE: Amar Gupta, MD and Robert Goldstein, MD, have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABS CC: Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

For information, please contact Megan Blanc, RN at [email protected]

Series location: 
Texas Oncology-Baylor Charles A. Sammons Cancer Center
3410 Worth Street, Ste 950
Dallas, TX 75246
United States

Sessions

Session Date
2026MMDD Dallas Liver TB - Template 01/13/2026 - 6:30am to 8:00am CST